차이
문서의 선택한 두 판 사이의 차이를 보여줍니다.
| 양쪽 이전 판이전 판다음 판 | 이전 판 | ||
| med:preeclampsia_aspirin [2018/12/09 00:51] – V_L | med:preeclampsia_aspirin [2025/10/30 00:39] (현재) – [임신중독증 저용량아스피린] V_L | ||
|---|---|---|---|
| 줄 1: | 줄 1: | ||
| - | {{tag>low dose aspirin | + | {{tag>BASA preeclampsia}} |
| {{page>: | {{page>: | ||
| ====== 임신중독증 저용량아스피린 ====== | ====== 임신중독증 저용량아스피린 ====== | ||
| - | + | [[med: | |
| + | 예방을 위한 | ||
| + | // | ||
| - | 저용량 [[aspirin]] 복용법은 일반적으로 | + | =====효과===== |
| + | 임신중독증 발생률의 위험도를 | ||
| + | ((A review of 45 randomized trials that included over 20,000 pregnant women taking daily low-dose aspirin showed significant evidence of the prevention of preeclampsia, | ||
| + | 임신 16주 이후에 복용하면 효과가 없었다. ((Low-dose aspirin | ||
| - | =====복용시작시기===== | + | 따라서 상기한 고위험군의 경우 임신초기부터 확인이 되어야 한다((Women at high risk for those outcomes should be identified in early pregnancy)) |
| - | You should start taking low-dose aspirin between weeks 12 and 16 of your pregnancy. | ||
| - | |||
| - | =====효과===== | ||
| - | A review of 45 randomized trials that included over 20,000 pregnant women taking daily low-dose aspirin showed significant evidence of the prevention of preeclampsia, | ||
| - | |||
| - | |||
| - | found a 2 to 5% risk reduction in the rate of preeclampsia. | ||
| =====적응증 ===== | =====적응증 ===== | ||
| 줄 23: | 줄 21: | ||
| * [[med: | * [[med: | ||
| * [[med: | * [[med: | ||
| - | * [[med:고혈압|만성 고혈압]] | + | * [[med:hypertension|만성 고혈압]] |
| - | * [[med:당뇨병|]] (1형 혹은 2형) | + | * [[med:diabetes_mellitus]] (1형 혹은 2형) |
| * 신장질환 (Renal disease) | * 신장질환 (Renal disease) | ||
| * 자가면역질환 (Autoimmune disease) ([[med: | * 자가면역질환 (Autoimmune disease) ([[med: | ||
| 줄 42: | 줄 40: | ||
| =====안전성===== | =====안전성===== | ||
| - | No increase in infant loss, growth | + | - 영아사망, |
| + | - 태반박리, | ||
| + | - 18개월까지 영아성장발달에 차이가 없다. | ||
| + | |||
| + | |||
| + | (( No increase in infant loss, growth | ||
| No statistically significant impact on risk of placental abruptions, postpartum hemorrhage (bleeding), or miscarriage to the mother; | No statistically significant impact on risk of placental abruptions, postpartum hemorrhage (bleeding), or miscarriage to the mother; | ||
| - | No differences in developmental outcomes of the infants up to age 18 months. | + | No differences in developmental outcomes of the infants up to age 18 months.)) |
| + | =====복용시작시기===== | ||
| + | |||
| + | 보통 임신 12주에서 16주 사이에 복용을 시작한다. ((You should start taking low-dose aspirin between weeks 12 and 16 of your pregnancy)) | ||
| =====중단시기===== | =====중단시기===== | ||
| - | When should I stop taking low-dose aspirin? | + | |
| - | It is very important that you ask your doctor when you should stop taking aspirin, as recommendations may be differ depending on your medical history. | + | 논란이 있다. |
| - | + | 36주 이후에는 분만가능성이 있고, 아스피린 복용시 출혈가능성이 증가하여 36주까지만 먹어야 한다는 의견과, 36주 이후에 [[med: | |
| - | There are opposing arguments regarding when to discontinue aspirin treatment. Some argue that aspirin should be discontinued at 36 weeks because of the possible bleeding risks associated with delivery. | + | ((There are opposing arguments regarding when to discontinue aspirin treatment. Some argue that aspirin should be discontinued at 36 weeks because of the possible bleeding risks associated with delivery. |
| - | Others argue, because most preeclampsia occurs after 36 weeks, that the aspirin may be beneficial to continue through delivery, into the postpartum period. | + | Others argue, because most preeclampsia occurs after 36 weeks, that the aspirin may be beneficial to continue through delivery, into the postpartum period)) |
| - | More research is needed, but again, it is imperative you discuss a stopping point with your healthcare professional if you are on a prenatal aspirin regimen. | ||
| {{: | {{: | ||
| https:// | https:// | ||